摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Thiophen-2-yl-5-trichloromethyl-4,5-dihydro-isoxazol-5-ol

中文名称
——
中文别名
——
英文名称
3-Thiophen-2-yl-5-trichloromethyl-4,5-dihydro-isoxazol-5-ol
英文别名
3-(Thiophen-2-yl)-5-(trichloromethyl)-4,5-dihydro-1,2-oxazol-5-ol;3-thiophen-2-yl-5-(trichloromethyl)-4H-1,2-oxazol-5-ol
3-Thiophen-2-yl-5-trichloromethyl-4,5-dihydro-isoxazol-5-ol化学式
CAS
——
化学式
C8H6Cl3NO2S
mdl
——
分子量
286.566
InChiKey
DBBIOIVPFKAWMH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    70.1
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    3-Thiophen-2-yl-5-trichloromethyl-4,5-dihydro-isoxazol-5-ol硫酸 作用下, 反应 2.0h, 以82%的产率得到3-Thiophen-2-yl-5-trichloromethyl-isoxazole
    参考文献:
    名称:
    卤乙酰化烯醇醚,19:3-(2-噻吩基)-和 3-(2-呋喃基)-5-三卤代甲基取代唑的合成
    摘要:
    1,1,1-三氟[氯]-4-甲氧基-4-[2-噻吩基]-3-丁烯-2-酮和1,1,1-三氟[氯]-4-甲氧基-4-的杂环化报道了将[2-呋喃基]-3-丁烯-2-酮转化为异恶唑和吡唑衍生物作为新型三卤甲基化双环杂环。
    DOI:
    10.1055/s-2005-872140
  • 作为产物:
    描述:
    (Z)-1,1,1-Trichloro-4-methoxy-4-thiophen-2-yl-but-3-en-2-one 在 盐酸羟胺 作用下, 以 甲醇 为溶剂, 以93%的产率得到3-Thiophen-2-yl-5-trichloromethyl-4,5-dihydro-isoxazol-5-ol
    参考文献:
    名称:
    卤乙酰化烯醇醚,19:3-(2-噻吩基)-和 3-(2-呋喃基)-5-三卤代甲基取代唑的合成
    摘要:
    1,1,1-三氟[氯]-4-甲氧基-4-[2-噻吩基]-3-丁烯-2-酮和1,1,1-三氟[氯]-4-甲氧基-4-的杂环化报道了将[2-呋喃基]-3-丁烯-2-酮转化为异恶唑和吡唑衍生物作为新型三卤甲基化双环杂环。
    DOI:
    10.1055/s-2005-872140
点击查看最新优质反应信息

文献信息

  • Structural investigations of 5-hydroxy-4,5-dihydroisoxazoles
    作者:Patrick T. Campos、Pablo Machado、Clarissa P. Frizzo、Dayse N. Moreira、Alexandre R. Meyer、Helio G. Bonacorso、Nilo Zanatta、Lucas C. Ducati、Roberto Rittner、Cláudio F. Tormena、Marcos A.P. Martins
    DOI:10.1016/j.molstruc.2011.09.051
    日期:2011.12
    The X-ray diffraction data determined for eight 3-(R-3), 4-(R-4), 4,4-(R-4/R-4') and/or 5-(R-5) 5-hydroxy-4,5-dihydroisoxazoles [where R-3 = Ph, R-4/R-4' = H/H, R-5 = CCl3 (1); R-3 = 4-Br-C6H4, R-4/R-4' = H/H, R-5 = CCl3 (2); R-3 = thien-2-yl, R-4/R-4' = H/H, R-5 = CCl3 (3); R-3 = Ph, R-4 = Ph, R-4' = OH, R-5 = Me (4); R-3 = Me, R-4/R-4' = N-OH, R-5 = Me (5); R-3 = CF3, R-4/R-4' = H/H, R-5 = CMe2CH2OH (6); R-3 = H, R-4 = 4-I-C6H4, R-4' = H, R-5 = 4-I-C6H4 (7): R-3/R-4 = -(CH2)(3)-, R-4' = H, R-5 = CF2CF2H (8);] are discussed. The crystalline structure of compounds 1-3 is described for the first time and crystalline structure of compounds 4-8 has already been described in literature. It was found that the supramolecular auto-organization of 1-8 is characterized by hydrogen bonds invariably involving the hemiacetal hydroxyl group. Compound 5 is the only exception, where the hydroxyl oxime group is the participant in the hydrogen bond. Compounds 4 and 8 present intermolecular contact between the hydroxyl group of the hemiacetal and the nitrogen atom of the 4,5-dihydroisoxazole ring. Compound 7 presents similar interaction, where the hydroxyl contact is with the oxygen atom of the 4,5-dihydroisoxazole ring. Moreover, the crystal structure of compound 6 was stabilized by O-H center dot center dot center dot O interaction between the hydroxyl group of hemiacetal and the hydroxyl group of the alcohol function attached at the 5-position of 4,5-dihydroisoxazole. The crystal structure of compounds 1-3, as described here for the first time, was similar to that of compounds 4 and 7, showing a hydrogen bond O(51)-H(51)center dot center dot center dot N(2) between the hydroxyl group and the nitrogen atom of the isoxazoline ring. This means that the crystal structure of these compounds was governed by hydrogen bonds O-H center dot center dot center dot N, involving the hydroxyl of the hemiacetal group and the nitrogen atom of the 4,5-dihydroisoxazole ring. This interaction is relatively robust, showing a pattern in the crystal packing. Compounds 1-3 also have their crystal stabilized by more weak interactions of type Cl center dot center dot center dot Cl, involving the chlorine atom of the trichloromethyl group. (C) 2011 Elsevier B.V. All rights reserved.
  • Haloacetylated Enol Ethers, 19: Synthesis of 3-(2-Thienyl)- and 3-(2-Furyl)-5-trihalomethyl Substituted Azoles
    作者:Alex Flores、Sergio Brondani、Lucas Pizzuti、Marcos Martins、Nilo Zanatta、Helio Bonacorso、Darlene Flores
    DOI:10.1055/s-2005-872140
    日期:——
    Heterocyclization of 1,1,1-trifluoro[chloro]-4-methoxy-4-[2-tienyl]-3-buten-2-one and 1,1,1-trifluoro[chloro]-4-methoxy-4-[2-furyl]-3-buten-2-ones into isoxazoles and pyrazoles derivatives as a new type of trihalomethylated bicyclic heterocycles is reported.
    1,1,1-三氟[氯]-4-甲氧基-4-[2-噻吩基]-3-丁烯-2-酮和1,1,1-三氟[氯]-4-甲氧基-4-的杂环化报道了将[2-呋喃基]-3-丁烯-2-酮转化为异恶唑和吡唑衍生物作为新型三卤甲基化双环杂环。
查看更多

同类化合物

(4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] 香豆素-6-羧酸 锌离子载体IV 钐(III) 离子载体 II 苯,(2,2-二氟乙烯基)- 聚二硫二噻唑烷 缩胆囊肽9 甲酰乙内脲 甲巯咪唑 甲基羟甲基油基噁唑啉 甲基5-羟基-3,5-二甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-氰基-4,5-二氢-1,2-恶唑-3-羧酸酯 甲基5-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-5-氧代-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4,5-二氮杂螺[2.4]庚-5-烯-6-羧酸酯 甲基4,5-二氢-5-乙基-1H-吡唑-1-羧酸酯 甲基(E)-3-[6-[1-羟基-1-(4-甲基苯基)-3-(1-吡咯烷基)丙基]-2-吡啶基]丙烯酰酸酯 甲基(5-氧代-4,5-二氢-1,2-恶唑-3-基)乙酸酯 环戊二烯并[d]咪唑-2,5(1H,3H)-二硫酮 溶剂黄93 溴化1-十六烷基-3-甲基咪唑 溴化1-十二烷基-2,3-二甲基咪唑 泰比培南酯中间体 泰比培南酯中间体 氨基甲硫酸,[2-[[(2-羰基-1-咪唑烷基)硫代甲基]氨基]乙基]-,O-甲基酯 异噻唑,4,5-二氯-2,5-二氢-2-辛基- 希诺米啉 四氟硼酸二氢1,3-二(叔-丁基)-4,5--1H-咪唑正离子 四唑硝基紫 噻唑丁炎酮 噻唑,4,5-二氢-4-(1-甲基乙基)-,(S)- 噁唑,4,5-二氢-4,4-二甲基-2-(5-甲基-2-呋喃基)- 噁唑,2-庚基-4,5-二氢- 咪唑烷基脲 吡嗪,2,3-二氢-5,6-二甲基-2-丙基- 叔-丁基3-羟基-1,4,6,7-四氢吡唑并[4,3-c]吡啶-5-羧酸酯 双吡唑啉酮 双[(S)-4-异丙基-4,5-二氢噁唑-2-基]甲烷 双((R)-4-(叔丁基)-4,5-二氢恶唑-2-基)甲烷 利美尼啶D4 利美尼啶 假硫代乙内酰脲 依达拉奉杂质DO 依达拉奉杂质 依达拉奉三聚体 依达拉奉 仲班酸